ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA to Review Zynquista (sotagliflozin) as Potential Treatment for Type 1 Diabetes
June 12, 2018The U.S. Food and Drug Administration (FDA) has accepted Sanofi's regulatory filing for Zynquista (sotagliflozin). The investigational oral treatment would be used in addition to insulin therapy to improve blood sugar control in adults with type 1 diabete
Pharma Sources Insight January 2025
